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On the other hand, several neu-
rological manifestations have been 
described following Mycoplasma
pneumonia [4, 5] infection, a com-
mon bacterium of the respiratory 
tract, including acute transverse
myelitis (ATM) [11]. 
Here we present a patient with 
typical NMO after M. pneumonia
infection that may represent an 
underestimated etiology for NMO. 
A previously healthy 32-year-old 
woman developed fever and a non-
productive cough. A chest x-ray 
showed an infiltrate in the right in-
ferior lobe. Respiratory symptoms
improved with erythromycin treat-
ment. Ten days later she experi-
enced paresthesia and weakness in
both legs, urinary retention and 
was admitted to our department. 
On neurological examination
she was alert. Cranial nerves were 
normal, but there was tetraparesis
with tetrahyperreflexia and hyp-
aesthesia with a sensory level at the
4th thoracic level. No signs of me-
ningism were present. Sphincter 
tone was reduced on rectal exami-
nation. The night after admission, 
the patient had to be transferred to 
our intensive care unit because of 
respiratory failure requiring intu-
bation. MRI investigation revealed 
a severe myelitis (Fig.1A and B).
CSF investigation showed 15
white blood cells per μL, 37 % poly-
morphonuclear neutrophils. There 
was no quantitative intrathecal 
immunoglobulin production. 
Serologic examinations showed
a highly positive complement fixa-
tion test (CFT) to M. pneumonia
(1:5120). An indirect immunofluo-
rescence assay was used to search 
for M. pneumonia antibodies in 
CSF and serum. This investigation
revealed an elevated titer of IgG 
antibodies specific to M. pneumo-
nia in the CSF. In combination with
an antibody specificity index of 9.5 
these results indicate an intrathecal 
production of IgG antibodies spe-
cific to M. pneumonia. Neither in 
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Sirs: Until recently neuromyelitis
optica (NMO) was regarded as a 
severe form of multiple sclerosis
(MS). But characteristic serologic
and neuroradiological findings and
particularly the discovery of the
specific NMO antibody by Lennon 
and colleagues [8] indicate that 
NMO is an autoimmune disease
different from MS. 
In a few patients, typical NMO is
associated with viral infection like 
HIV [3], Dengue fever [10], vari-
cella infection [1], infectious
mononucleosis [12] and hepatitis A 
virus [6]. The only bacterial agent 
that has been associated with NMO
is Mycobacterium tuberculosis [2].
CSF nor in serum were there signs 
of another acute infection or auto-
immune disorder. NMO-IgG anti-
aquaporin-4 antibodies [8] were
negative. Within 4 days the tetrapa-
resis progressed to tetraplegia. 
Sensory level of hypesthesia moved 
up to C4 and bilateral blindness
occurred. An immunosuppressive 
therapy with methylprednisolone
and later with plasma exchange 
and mitoxantron was initiated in
addition to the initial antibiotics 
therapy. Blindness resolved slowly 
within the following months. After 
1 year, the patient had regained
almost full function of both upper
extremities. Visual function was 
normal, but she was still paraspas-
tic and -plegic. CFT to M. pneumo-
nia had decreased to 1:120 and spi-
nal MRI revealed an atrophy 
(Fig.1C).
In this case, the development of 
symptoms after pneumonia and
associated increase of M. pneumo-
nia antibody titres both in serum
and CSF strongly suggests that the 
mycoplasma infection is involved
in this NMO syndrome.
Several neurological complica-
tions including ADEM and ATM
have been described after M. pneu-
monia infection [5, 9]. Both direct
CNS infection and an autoimmune 
mechanism triggered by M. pneu-
monia are possible. Since direct 
PCR evidence for M. pneumonia is
only seldom found in CSF [11], it is 
often difficult to differentiate be-
tween both possibilities [5]. The 
clinical syndrome with bilateral 
optic neuritis and longitudinally 
extensive myelitis is typical for 
NMO and, to the best of our knowl-
edge, has not been reported to date
in association with M. pneumonia
infection. Overall, an autoimmune 
parainfectious pathogenesis seems
more likely than a direct infection
since the symptoms started late
after the pneumonia, progressed in
spite of an adequate antibiotic
treatment, and since CSF analysis
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revealed only weak inflammatory 
signs in spite of a strong anti-
mycoplasma antibodies titre. In 
this case, the recently published
revised diagnostic criteria for
NMO are fulfilled [13] even though 
the anti-aquaporin-4 antibodies
[7], which have a 90 % specificity 
for NMO, were not detected in the 
CSF or blood. 
We postulate that this case
represents an anti-aquaporin-4
antibody negative NMO syndrome 
following M. pneumonia infection. 
We propose that in patients with 
NMO syndrome, especially cases
with rapid symptom onset, a com-
prehensive search for possible 
infectious etiologies including M. 
pneumonia infection should be
performed. 
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Fig. 1 Spinal MRI. A Sagittal T2-weighted TSE images reveal progressive T2-hyperintense and progressive
swelling of the spinal cord at the level of C2-Th1 and Th4-Th9 16 days after symptoms onset. B T1-weighted SE
images show hemorrhagic transformation at the level of Th5–Th9. C Follow-up examination after 10 months
reveal severe atrophy of the thoracic cord
